Select Page

NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) breached their fiduciary duties or violated the federal securities laws in connection with the company’s merger with Covis Group S.á. r.l.